Script Source Pharmacy L L C is categorized under Wholesale Pharmaceutical Products in Pearland, TX and active since 2011.
Script Source Pharmacy L L C was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Monique H Sanders at the company’s single location by writing to 2512 Sunfire Lane, Pearland, Texas TX 77584 or by phoning (281) 997-3408. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Script Source Pharmacy L L C |
Contact Person: | Monique H Sanders |
Address: | 2512 Sunfire Lane, Pearland, Texas 77584 |
Phone Number: | (281) 997-3408 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Script Source Pharmacy L L C was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Monique H Sanders for inquiries that concern Script Source Pharmacy L L C by calling the company number (281) 997-3408, as your correspondence is most welcome. Additionally, the physical location of the single location of Script Source Pharmacy L L C can be found at the coordinates 29.56369,-95.358219 as well as the street address 2512 Sunfire Lane in Pearland, Texas 77584.
For its online presence, you may visit Script Source Pharmacy L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.